---
title: "Kareems Spun Silk Ltd (514294) — Share Price, Financials & Analysis"
symbol: "514294"
company: "Kareems Spun Silk Ltd"
canonical: "https://tapetide.com/stocks/514294"
bse_code: "514294"
generated_at: "2026-10-13T10:58:15.988Z"
---

# Kareems Spun Silk Ltd (514294)

Canonical page: https://tapetide.com/stocks/514294

## Company

- **BSE Code:** 514294
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Company has high debtors of 166 days.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -100% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6473 | 6851 | 7219 | 7352 | 7580 | 7567 | 7796 | 7979 | 8382 | 7868 | 8286 | 8646 |
| Expenses | 5477 | 5702 | 5846 | 5753 | 5920 | 5949 | 6230 | 6401 | 6622 | 6265 | 6608 | 6873 |
| Operating Profit | 996 | 1149 | 1373 | 1599 | 1660 | 1618 | 1566 | 1578 | 1760 | 1603 | 1678 | 1773 |
| OPM % | 15 | 17 | 19 | 22 | 22 | 21 | 20 | 20 | 21 | 20 | 20 | 21 |
| Other Income | 135 | 47 | 188 | 163 | 14 | 221 | 136 | 159 | 135 | 107 | 122 | 123 |
| Interest | 56 | 57 | 68 | 76 | 89 | 111 | 113 | 118 | 115 | 98 | 95 | 93 |
| Depreciation | 346 | 327 | 418 | 423 | 354 | 404 | 382 | 419 | 444 | 406 | 429 | 465 |
| Profit before tax | 730 | 812 | 1076 | 1262 | 1230 | 1324 | 1207 | 1200 | 1335 | 1207 | 1276 | 1339 |
| Tax % | 31 | 30 | 30 | 26 | 26 | 31 | 32 | 30 | 32 | 32 | 34 | 32 |
| Net Profit | 506 | 570 | 752 | 940 | 907 | 918 | 817 | 846 | 903 | 824 | 848 | 910 |
| EPS in Rs | 8.64 | 9.74 | 12.92 | 15.98 | 15.51 | 15.69 | 14.07 | 14.56 | 15.56 | 14.2 | 14.61 | 15.67 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.07 | 0.29 | 1.22 | 1.37 | 0 | 0.11 |
| Expenses | 0.19 | 0.52 | 1.67 | 1.34 | 0.15 | 0.18 |
| Operating Profit | -0.12 | -0.23 | -0.45 | 0.03 | -0.15 | -0.07 |
| OPM % | -171.43 | -79.31 | -36.89 | 2.19 | — | -63.64 |
| Other Income | -0.05 | 0 | 0.03 | 0 | 0.15 | 0.04 |
| Interest | 0 | 0 | 0 | 0.02 | 0 | 0 |
| Depreciation | 0.53 | 0.53 | 0.53 | 0.53 | 0 | 0 |
| Profit before tax | -0.7 | -0.76 | -0.95 | -0.52 | 0 | -0.03 |
| Tax % | 0 | 0 | 0 | 0 | — | -33.33 |
| Net Profit | -0.7 | -0.76 | -0.95 | -0.52 | -0.01 | -0.02 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 |
| Reserves | -7.28 | -6.83 | -8.02 | -8.54 | -10.81 | -10.83 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 7.2 | 6.64 | 7.67 | 8.48 | 5 | 5.14 |
| Total Liabilities | 6.39 | 6.28 | 6.12 | 6.41 | 0.66 | 0.78 |
| Fixed Assets | 4.85 | 4.36 | 3.88 | 3.36 | 0.55 | 0.55 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.54 | 1.92 | 2.24 | 3.05 | 0.11 | 0.23 |
| Total Assets | 6.39 | 6.28 | 6.12 | 6.41 | 0.66 | 0.78 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.3 | -0.73 | -1.02 | -0.54 | 0.04 | -0.03 |
| Cash from Investing Activity | 0.33 | 0.73 | 1 | 0.58 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.03 | 0 | -0.02 | 0.04 | 0.04 | -0.03 |
| Free Cash Flow | 0.03 | -0.77 | -1.04 | -0.5 | 0.04 | -0.03 |
| CFO/OP | 250 | 317 | 227 | -1800 | -27 | 43 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 4640.71 | 1283.79 | 478.69 | 639.42 | — | 165.91 |
| Inventory Days | 4927.5 | 701.92 | 99.55 | 113.77 | — | 0 |
| Days Payable | 103295 | 7749.23 | 2366.97 | 3166.49 | — | — |
| Cash Conversion Cycle | -93726.79 | -5763.51 | -1788.74 | -2413.31 | — | 165.91 |
| Working Capital Days | -29773.57 | -6003.62 | -1633.52 | -1465.33 | — | -16026.82 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51.87% | 51.87% | 51.87% | 52.01% | 51.94% | 51.83% | 51.84% | 51.84% | 51.82% | 51.82% |
| FIIs | 20.99% | 17.99% | 21.47% | 22.26% | 24.37% | 20.83% | 23.03% | 18.01% | 15.33% | 13.95% |
| DIIs | 12.76% | 15.64% | 13.69% | 12.56% | 13.24% | 17.47% | 15.09% | 23.28% | 26.23% | 27.66% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.03% |
| Public | 14.38% | 14.5% | 12.97% | 13.16% | 10.45% | 9.86% | 10.06% | 6.87% | 6.61% | 6.55% |
| No. of Shareholders | 191317 | 218029 | 176406 | 206824 | 232634 | 338639 | 343617 | 244575 | 269323 | 236859 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51.84% | 51.84% | 51.84% | 51.84% | 51.84% | 51.8% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FIIs | 23.03% | 24.12% | 22.45% | 20.72% | 18.01% | 16.73% | 16.59% | 16.29% | 15.33% | 14.38% | 14.21% | 13.95% |
| DIIs | 15.09% | 15.73% | 18.29% | 20.6% | 23.28% | 24.77% | 25.14% | 25.21% | 26.23% | 26.93% | 27.6% | 27.66% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.03% |
| Public | 10.06% | 8.31% | 7.43% | 6.85% | 6.87% | 6.69% | 6.45% | 6.67% | 6.61% | 6.88% | 6.37% | 6.55% |
| No. of Shareholders | 343617 | 293214 | 259638 | 241944 | 244575 | 238622 | 248488 | 257962 | 269323 | 272208 | 247662 | 236859 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1353.49 | Sell |
| EMA (10) | 1350.55 | Sell |
| SMA (20) | 1397.61 | Sell |
| EMA (20) | 1375.37 | Sell |
| SMA (50) | 1398.31 | Sell |
| EMA (50) | 1400.93 | Sell |
| SMA (100) | 1432.12 | Sell |
| EMA (100) | 1439.69 | Sell |
| SMA (200) | 1547.03 | Sell |
| EMA (200) | 1520.92 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 32.42 | Neutral |
| MACD (12,26,9) | -25.69 | Sell |
| Stochastic (14,3,3) | 6.7 | Buy |
| ADX (14) | 21.79 | Neutral |
| Williams %R (14) | -93.95 | Buy |
| ATR (14) | 36.77 | Neutral |
| ROC (12) | -7.19 | Sell |
| Stoch RSI (14) | 4.69 | Buy |
| UO (7,14,28) | 31.07 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0e29da44-919d-403e-ae2c-807923749245.pdf) |
| 2026-03-04 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/xml-data/corpfiling/AttachLive/db9c31a1-36b2-4cda-9116-7eee827b7478.pdf) |
| 2026-03-02 | [Clarification On Media Report, 'Aurobindo Pharma'S P Sarath Chandra Reddy Acquitted In Delhi Liquor Scam Case'.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c3f08b1-1d03-4655-961c-1a50ef63c08e.pdf) |
| 2026-03-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c710145b-9d23-4795-a031-51c96437a722.pdf) |
| 2026-02-27 | [Completion Of US FDA Inspection At Unit I Of Eugia Pharma Specialities Ltd](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca4a53f9-f858-4a51-9ccc-9f781e403939.pdf) |
| 2026-02-26 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/xml-data/corpfiling/AttachLive/727fa546-25f2-4459-a804-c4bf4cf09601.pdf) |
| 2026-02-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/xml-data/corpfiling/AttachLive/53a1fe2c-396b-469b-b49d-329e03e25041.pdf) |
| 2026-02-24 | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ae316403-e63a-4ad3-ad22-476de6a8299a.pdf) |
| 2026-02-24 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8303d77a-c3b9-4e5e-acd4-103ac0c64939.pdf) |
| 2026-02-19 | [Intimation Of Orders Passed By The Goods & Services Tax Department](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e82cfd2a-28fe-4095-a8e9-3df913cf8b32.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e3a5b88-6f3b-4a5d-8d07-7186fd4b1f25.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2f11ada-795d-4215-acbf-3df412cdc882.pdf) |
| 2023 | [Financial Year 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0aa8e6e6-da93-48a3-a74d-9d50683dc2a7.pdf) |
| 2022 | [Financial Year 2022](https://www.bseindia.com/bseplus/AnnualReport/524804/73589524804.pdf) |
| 2021 | [Financial Year 2021](https://www.bseindia.com/bseplus/AnnualReport/524804/69269524804_25_08_21.pdf) |
| Mar 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/524804/5248040320.pdf) |
| Mar 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport/524804/5248040319.pdf) |
| Mar 2018 | [Financial Year 2018](https://www.bseindia.com/bseplus/AnnualReport/524804/5248040318.pdf) |
| Mar 2017 | [Financial Year 2017](https://www.bseindia.com/bseplus/AnnualReport/524804/5248040317.pdf) |
| Mar 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport/524804/5248040316.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/32148f1f-47ad-42f0-a8e7-8a15130df027.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca5c35e2-908b-4fbc-94d1-07553c6f2594.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38fa1702-0014-46be-805a-43fd18f17cc1.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cba3da3b-6c58-4ea1-99f1-5853086d9a8a.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18df2504-0212-4327-971e-954b70abb3bf.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a1fdc43-c10e-460c-a60f-512ed9cd4218.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5216098b-a943-44ca-a1ab-72094c7f334c.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2fa5dd59-59af-4bda-af84-37083f4141c5.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fefdeb36-1743-418d-a02e-7f05451a69b3.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06a705ce-0ecd-42a2-bb8e-6750a29e8330.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-03-11 | Credit rating update — India Ratings |
| 2023-12-20 | Credit rating update — India Ratings |
| 2022-10-20 | Credit rating update — India Ratings |
| 2021-08-06 | Credit rating update — India Ratings |
| 2021-08-04 | Credit rating update — India Ratings |
| 2020-07-03 | Credit rating update — India Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:58:15.988Z.